22382 - Update on Psoriasis and PsA: Best Practices in Dermatology



Friday, April 20, 2018, 12:00 AM - Saturday, April 20, 2019, 11:59 PM


AMA PRA Category 1 Credits™ (0.50 hours), AMA PRA Category 1 Credits™ Designated (0.50 hours)


Specialties - Dermatology, Nursing, Primary Care, Rheumatology


Despite numerous advances in treatment for psoriasis and psoriatic arthritis (PsA), many patients continue to experience negative health consequences that could be prevented or improved with optimal evidence-based care. Dermatology, rheumatology, and primary care clinicians can improve outcomes for their patients by increasing their knowledge and competency in diagnosis, management, and interdisciplinary care coordination. This activity will address best practices in dermatology as well as specialty collaboration and comanagement in the treatment of psoriatic disease.



Free Online Certified CME

Objectives
Upon completion of this educational activity, participants should be able to:

  1. Assess patients with psoriasis for signs and symptoms of PsA;
  2. Discuss strategies for selecting psoriasis and PsA treatment that is tailored to specific disease and patient characteristics;
  3. Describe strategies to facilitate effective multidisciplinary care of patients with psoriasis and with PsA.


This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Cincinnati and MCM Education.

The University of Cincinnati is accredited by the ACCME to provide continuing medical education for physicians. The University of Cincinnati designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.



Faculty & Disclosure / Conflict of Interest Policy

In accordance with ACCME requirements, the University of Cincinnati has a conflict of interest policy that requires faculty to disclose relevant financial relationships related to the content of their presentations/materials. Any potential conflicts are resolved so that presentations are evidence-based and scientifically balanced. The planning committee and those in a position to control the content of this activity have disclosed no relevant financial relationships.

All planning committee members/faculty were determined to have no conflicts of interest pertaining to this activity. To view faculty disclosures, visit the faculty tab.

Medical Director & Program Planners

MCM Education

Terry Ann Glauser, MD, MPH, Vice President, Medical Affairs
Kathleen Hines, Vice President, Editorial Services

University of Cincinnati Continuing Medical Education Office

Bruce Gebhardt, MD, Professor, Physician Reviewer
Deborah Cole, Program Coordinator
Jennifer Holzberger, Program Coordinator
Susan P. Tyler, MEd, CMP, CHCP, Director

Disclosure of Unlabeled Use

The faculty of this educational activity may include discussions of products or devices that are not currently labeled for use by the FDA. Faculty members have been advised to disclose to the audience any reference to an unlabeled or investigational use.

No endorsement of unapproved products or uses is made or implied by coverage of these products or uses in our reports. No responsibility is taken for errors or omissions in reports.

Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.The materials presented here are used with the permission of the authors and/or other sources. These materials do not necessarily reflect the views of University of Cincinnati, MCM Education or any of its supporters.

The materials presented here are used with the permission of the authors and/or other sources. These materials do not necessarily reflect the views of University of Cincinnati, MCM Education or any of its supporters.